Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Irish Journal of Medical Science (1971 -)
Published in: Irish Journal of Medical Science (1971 -) 1/2011

01-03-2011 | Original Article

Normative curves of fetal nasal bone length for the ethnic Chinese population

Authors: W.-H. Chiu, T.-H. Tung, Y.-s. Chen, W.-H. Wang, S.-M. Lee, S.-C. Horng, F.-Y. Yang

Published in: Irish Journal of Medical Science (1971 -) | Issue 1/2011

Login to get access

Abstract

Objective

The purpose of this study is to determine the association between fetal nasal bone length (NBL) and gestational age (GA), biparietal diameter (BPD) and head circumference (HC) in women undergoing prenatal assessments and Down syndrome screening.

Methods

Cross-sectional data were obtained from 3,003 women with singleton pregnancies who underwent a prenatal ultrasound examination at the Department of Obstetrics and Gynecology, Cheng Hsin General Hospital between August 2006 and July 2009.

Results

Statistical analyses involved linear regression. NBL with GA, BPD and HC as measured between 14+0 and 35+6 weeks of gestation were linearly related.

Conclusions

Using multiple parameters(GA, BPD and HC) to estimate NBL is more accurate than using than using GA or BPD or HC alone, as indicated by the higher predictive value.
Literature
1.
Bromley B, Lieberman E, Shipp TD, Benacerraf BR (2002) Fetal nose bone length: a marker for Down syndrome in the second trimester. J Ultrasound Med 21:1387–1394PubMed
2.
Bell R, Rankin J, Donaldson LJ (2003) Down’s syndrome: occurrence and outcome in the north of England, 1985–99. Paediatr Perinat Epidemiol 17:33–39CrossRefPubMed
3.
Van den Hof MC, Wilson RD (2005) Fetal soft markers in obstetric ultrasound. J Obstet Gynaecol Can 27:592–636PubMed
4.
Monni G, Zoppi MA, Ibba RM, Floris M, Manca F, Axiana C (2005) Nuchal translucency and nasal bone for trisomy 21 screening: single center experience. Croat Med J 46:786–791PubMed
5.
Bunduki V, Ruano R, Miguelez J, Yoshizaki CT, Kahhale S, Zugaib M (2003) Fetal nasal bone length: reference range and clinical application in ultrasound screening for trisomy 21. Ultrasound Obstet Gynecol 21:156–160CrossRefPubMed
6.
Otano L, Aiello H, Igarzabal L, Matayoshi T, Gadow EC (2002) Association between first trimester absence of fetal nasal bone on ultrasound and Down syndrome. Prenat Diagn 22:930–932CrossRefPubMed
7.
Cicero S, Bindra R, Rembouskos G, Spencer K, Nicolaides KH (2003) Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11 to 14 weeks. Prenat Diagn 23:306–310CrossRefPubMed
8.
Collado F, Bombard A, Li V, Julliard K, Aptekar L, Weiner Z (2005) Ethnic variation of fetal nasal bone length between 11–14 weeks’ gestation. Prenat Diagn 25:690–692CrossRefPubMed
9.
Sonek JD, McKenna D, Webb D, Croom C, Nicolaides K (2003) Nasal bone length throughout gestation: normal ranges based on 3537 fetal ultrasound measurements. Ultrasound Obstet Gynecol 21:152–155CrossRefPubMed
10.
Chen M, Lee CP, Leung KY, Hui PW, Tang MH (2004) Pilot study on the midsecond trimester examination of fetal nasal bone in the Chinese population. Prenat Diagn 24:87–91CrossRefPubMed
11.
Kanagawa T, Fukuda H, Kinugasa Y, Son M, Shimoya K, Murata(ed) Y (2006) Mid-second trimester measurement of fetal nasal bone length in the Japanese population. J Obstet Gynaecol Res 32:403–407CrossRefPubMed
12.
Jung E, Won HS, Lee PR, Kim A (2007) Ultrasonographic measurement of fetal nasal bone length in the second trimester in Korean population. Prenat Diagn 27:154–157CrossRefPubMed
13.
Zelop CM, Milewski E, Brault K, Benn P, Borgida AF, Egan JF (2005) Variation of fetal nasal bone length in second-trimester fetuses according to race and ethnicity. J Ultrasound Med 24:1487–1489PubMed
14.
Shin JS, Yang JH, Chung JH, Kim MY, Ryu HM, Han (ed.) JY (2006) The relation between fetal nasal bone length and biparietal diameter in the Korean population. Prenat Diagn 26:321–323CrossRefPubMed
15.
Shohat T, Romano-Zelekha O (2001) Ultrasonographic measurements of fetal femur length and biparietal diameter in an Israeli population. Isr Med Assoc J 3:166–168PubMed
16.
Nisbet D, Robinson H, Halliday J, de CL (2002) Australian Society of Ultrasound in Medicine (ASUM) Policy Statement on normal ultrasonic fetal measurements. Aust N Z J Obstet Gynaecol 42:101–103CrossRefPubMed
17.
Cicero S, Bindra R, Rembouskos G, Tripsanas C, Nicolaides KH (2002) Fetal nasal bone length in chromosomally normal and abnormal fetuses at 11–14 weeks of gestation. J Matern Fetal Neonatal Med 11:400–402PubMed
18.
Cicero S, Curcio P, Papageorghiou A, Sonek J, Nicolaides K (2001) Absence of nasal bone in fetuses with trisomy 21 at 11–14 weeks of gestation: an observational study. Lancet 358:1665–1667CrossRefPubMed
19.
Guis F, Ville Y, Vincent Y, Doumerc S, Pons JC, Frydman R (1995) Ultrasound evaluation of the length of the fetal nasal bones throughout gestation. Ultrasound Obstet Gynecol 5:304–307CrossRefPubMed
20.
Sonek JD, Nicolaides KH (2002) Prenatal ultrasonographic diagnosis of nasal bone abnormalities in three fetuses with Down syndrome. Am J Obstet Gynecol 186:139–141CrossRefPubMed
21.
Cusick W, Provenzano J, Sullivan CA, Gallousis FM, Rodis JF (2004) Fetal nasal bone length in euploid and aneuploid fetuses between 11 and 20 weeks’ gestation: a prospective study. J Ultrasound Med 23:1327–1333PubMed
22.
Gamez F, Ferreiro P, Salmean JM (2004) Ultrasonographic measurement of fetal nasal bone in a low-risk population at 19–22 gestational weeks. Ultrasound Obstet Gynecol 23:152–153CrossRefPubMed
23.
Naraphut B, Uerpairojkit B, Chaithongwatthana S, Tannirandorn Y, Tanawattanacharoen S, Manotaya (ed.) S (2006) Nasal bone hypoplasia in trisomy 21 at 15 to 24 weeks’ gestation in A high risk Thai population. J Med Assoc Thai 89:911–917PubMed
24.
Schluter PJ, Pritchard G, Gill MA (2007) Using ultrasonic fetal size measurements to estimate gestational age in Brisbane, Australia. Australas Radiol 51:46–52CrossRefPubMed
25.
Merz E, Wellek S (1996) Normal fetal growth profile—a uniform model for calculating normal curves for current head and abdomen parameters and long limb bones. Ultraschall Med 17:153–162CrossRefPubMed
26.
Salomon LJ, Bernard JP, Ville Y (2007) Estimation of fetal weight: reference range at 20–36 weeks’ gestation and comparison with actual birth-weight reference range. Ultrasound Obstet Gynecol 29:550–555CrossRefPubMed
27.
Odibo AO, Sehdev HM, Sproat L, Parra C, Odibo L, Dunn (ed.) L (2006) Evaluating the efficiency of using second-trimester nasal bone hypoplasia as a single or a combined marker for fetal aneuploidy. J Ultrasound Med 25:437–441 quiz 443PubMed
Metadata
Title
Normative curves of fetal nasal bone length for the ethnic Chinese population
Authors
W.-H. Chiu
T.-H. Tung
Y.-s. Chen
W.-H. Wang
S.-M. Lee
S.-C. Horng
F.-Y. Yang
Publication date
01-03-2011
Publisher
Springer-Verlag
Published in
Irish Journal of Medical Science (1971 -) / Issue 1/2011
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-010-0520-4

Other articles of this Issue 1/2011

Irish Journal of Medical Science (1971 -) 1/2011 Go to the issue

Case Report

Pulmonary artery leiomyosarcoma: an unusual cause of shortness of breath

Original Article

Pandemic H1N1 (2009) and renal failure: the experience of the Irish national tertiary referral centre

Original Article

17β-Estradiol attenuates diet-induced insulin resistance and glucose intolerance through up-regulation of caveolin-3

Letter to the Editor

Re: O’Connor KM and Kiely EA: Lessons learned using Snodgrass hypospadias repair (Irish J Med Sci 175:37)

Original Article

Periconceptional folic acid prevents miscarriage in Irish families with neural tube defects

Brief Report

First reported deliveries in Ireland using surgically retrieved sperm for non-obstructive azoospermia
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits